Skip to content
HowShorted

C4 Therapeutics, Inc. short interest in 2024

In 2024, C4 Therapeutics, Inc.'s disclosed short interest ran from 11.26% of shares outstanding on 12 Jan 2024 to 12.19% on 31 Dec 2024, a change of +0.93 percentage points. The year's high was 21.14% on 14 Jun 2024 and its low 4.32% on 29 Feb 2024, averaging 12.83% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.14 days on 30 Aug 2024. Full history: C4 Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for C4 Therapeutics, Inc. in 2024

2024 in figures

Start of year
11.26% (12 Jan 2024)
End of year
12.19% (31 Dec 2024)
Change
+0.93 pp
High
21.14% (14 Jun 2024)
Low
4.32% (29 Feb 2024)
Average
12.83%
Highest days to cover
12.14 (30 Aug 2024)
SEC filings marked
8

Every report in 2024

C4 Therapeutics, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 202411.26%1.00
31 Jan 20246.81%1.00
15 Feb 20244.63%1.20
29 Feb 20244.32%1.0010-K filed, results (8-K)
15 Mar 20247.71%1.55
28 Mar 202413.34%5.18
15 Apr 202413.94%7.13
30 Apr 202414.73%9.09
15 May 202416.49%8.0010-Q filed, results (8-K)
31 May 202419.28%11.81
14 Jun 202421.14%11.69
28 Jun 202412.81%2.63
15 Jul 202416.90%8.03
31 Jul 202415.10%6.28
15 Aug 202415.15%11.5610-Q filed, results (8-K)
30 Aug 202416.77%12.14
13 Sep 202417.20%7.75
30 Sep 202415.88%11.12
15 Oct 20249.59%8.63
31 Oct 20248.29%10.5210-Q filed, results (8-K)
15 Nov 202410.48%6.10
29 Nov 202411.31%6.76
13 Dec 202412.56%4.37
31 Dec 202412.19%4.31

See also: C4 Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.